Hashimoto's thyroiditis associated with recurrent transverse myelopathy;Myélite transverse à rechutes associée à une thyroïdite d'Hashimoto

Revue Neurologique

Volumn 159, Issue 6-7 I, 2003, Pages 673-677

  Drouet, A ^a   Guilloton, L ^a   Jacquin, O ^b   Renoult, P A ^a   Felten, D ^a  

^a Service de Neurologie   (France)

^b Hop Instruct Armees Desgenettes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; THYROID ANTIBODY;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; EUTHYROIDISM; FEMALE; HASHIMOTO DISEASE; HUMAN; LABORATORY TEST; LONG TERM CARE; MYELOOPTIC NEUROPATHY; NEUROLOGIC DISEASE; PARAPLEGIA; RECURRENT DISEASE; TREATMENT OUTCOME;

ATROPHY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PARAPLEGIA; RECURRENCE; SPINAL CORD; SPINAL CORD INJURIES; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 0242600798     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. AZUMA T, UEMICHI T, FUNAUCHI M, DOI S, MATSUBARA T. (2000). Myelopathy associated with Hashimoto's disease. J Neurol Neurosurg Psychiatry, 68: 681-682.
2. BRAIN L, JELLINEK EH, BALL K. (1966). Hashimoto's disease and encephalopathy. Lancet, 2: 512-514.
3. CALVET D, TOUZE E, DELEGUE P, BERTHERAT J, ZUBER M. (2002). Syndrome des membres raides associé à une encéphalopathie d'Hashimoto: effet favorable des corticoïdes. Rev Neurol, 158: 602-604.
4. DE SEZE J, STOJKOVIC T, FERRIBY D et al. (2002). Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci, 197: 57-61.
5. FILIPPI M, ROCCA M, MOIOLA L et al. (1999). MRI and magnetization transfert imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica. Neurology, 53: 1705-1710.
6. KARNI A, ABRAMSKY O. (1999). Association of MS with thyroid disorders. Neurology, 53: 883-885.
7. KAWAI H, KASHIWAGI S, INUI T, TAMAKI Y, SANO Y, SAITO S. (1991). HTLV1-associated myelopathy (HAM/TP) with Hashimoto's thyroiditis. Tokushima J Exp Med, 38: 99-102.
8. KREISS Y, COHEN O, PRAS E, ACHIRON A. (1999). Subacute thyroiditis in a patient with MS treated with interferon beta-1a. Neurology, 53: 1606.
9. LUCCHINETTI CF, MANDLER RN, MC GAVERN D et al. (2002). A role for humoral mechanisms in the pathogenis of Devic's neuromyelitis optica. Brain, 125: 1450-1461.
10. OHSAKO S, ELKON LB. (1999). Apoptosis in effector phase of autoimmune diabetes, multiple sclerosis and thyroiditis. Cell Death Differ, 6: 13-21.
11. O'RIORDAN JI, GALLAGHER HL, THOMPSON AJ et al. (1996). Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry, 60: 382-387.
12. PERROT X, GIRAUD P, BIACABE AG et al. (2002). Encéphalopathie d'Hashimoto: une observation anatomo-clinique. Rev Neurol, 158: 461-466.
13. SAKUMA R, FUJIHARA K, SATO N, MOCHIZUKI H, ITOYAMA Y. (1999). Optic-spinal form of multiple sclerosis and anti-thyroid autoantibodies. J Neurol, 246: 449-453.
14. SHAW PJ, WALLS TJ, NEWMAN PK, CLELAND PG, CARTLIDGE NEF. (1991). Hashimato's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers-report of 5 cases. Neurology, 41: 228-233.
15. VERNANT JC, CABRE P, SMADJA D, MERLE H, CAUBARRERE I, MIKOL J, POSER CM. (1997). Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology, 48: 58-64.
16. WINGERCHUK DM, HOGANCAMP WF, O'BRIEN PC, WEINSHENKER BG. (1999). The clinical course of neuromyelitis optica (Devic's syndrome). Neurology, 53: 1107-1114.